Targeted elimination of prostate cancer by genetically directed human T lymphocytes.
Times cited: 74
Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.
Times cited: 324
A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?.
Critical reviews in immunology.
Times cited: 71
- Overview of evolving strategies incorporating prostate-specific membrane antigen as target for therapy. Molecular urology. 2000 Information Resource GET IT
- Prostate-specific membrane antigen (PSMA)-specific monoclonal antibodies in the treatment of prostate and other cancers. Cancer and Metastasis Reviews. 1999 Academic Article GET IT
- Cancer patient T cells genetically targeted to prostate-specific membrane antigen specifically lyse prostate cancer cells and release cytokines in response to prostate-specific membrane antigen. Neoplasia. 1999 Academic Article GET IT